Expression of an anti-botulinum toxin A neutralizing single-chain Fv recombinant antibody in transgenic tobacco

Vaccine

Volumn 24, Issue 12, 2006, Pages 2079-2086

  Almquist, Kurt C ^a   McLean, Michael D ^a   Niu, Yongqing ^a   Byrne, Greg ^a   Olea Popelka, Fernando C ^a   Murrant, Coral ^a   Barclay, Jack ^a   Hall, J Christopher ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

Clearance; scFv; Tobacco; Toxin

Indexed keywords

BOTULINUM ANTISERUM; BOTULINUM TOXIN A; MONOCLONAL ANTIBODY; RECOMBINANT ANTIBODY; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; SYNTHETIC DNA;

ANIMAL TISSUE; ANTIBODY SCREENING; ARTICLE; BIOREACTOR; CONTROLLED STUDY; EXPANDED BED ADSORPTION; MOUSE; MUSCLE TWITCH; NEUROMUSCULAR SYNAPSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TOBACCO; TRANSGENIC PLANT;

BOTULINUM TOXIN TYPE A; CLOSTRIDIUM BOTULINUM; IMMUNOGLOBULIN FRAGMENTS; PHARMACEUTICAL PREPARATIONS; PLANTS, GENETICALLY MODIFIED; RECOMBINANT FUSION PROTEINS; TOBACCO;

EID: 32844471433     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.11.014     Document Type: Article

References (50)

1. S.S. Arnon, R. Schechter, T.V. Inglesby, D.A. Henderson, J.G. Bartlett, and M.S. Ascher Botulinum toxin as a biological weapon: medical and public health management JAMA 285 8 2001 1059 1070
2. J.L. Middlebrook, and D.R. Franz Botulinum toxins F.R. Sidell E.T. Takafuji Franz Medical aspects of chemical and biological warfare 1997 Office of the Surgeon General Washington, DC 643 654 Textbook of military medicine, Part 1, vol. 3
3. D.R. Franz, L.M. Pitt, M.A. Clayton, M.A. Hanes, and K.J. Rose Efficacy of prophylactic and therapeutic administration of antitoxin for inhalation botulism B.R. DasGupta Botulinum and tetanus neurotoxins: neurotransmission and biomedical aspects 1993 Plenum Press New York, NY 473 476
4. B.A. Herrero, A.E. Ecklung, C.S. Streett, D.F. Ford, and J.K. King Experimental botulism in monkeys: a clinical pathological study Exp Mol Pathol 6 1967 84 95
5. A.B. Scott, and D. Suzuki Systemic toxicity of botulinum toxin by intramuscular injection in the monkey Mov Disord 3 1988 333 335
6. A. Casadevall Passive antibody administration (immediate immunity) as a specific defense against biological weapons Emerg Infect Dis 8 2002 833 841
7. C.O. Tacket, W.X. Shandera, J.M. Mann, N.T. Hargrett, and P.A. Blake Equine antitoxin use and other factors that predict outcome in Type A foodborne botulism Am J Med 76 1984 794 798
8. R.C. Hibbs, J.T. Weber, A. Corwin, R.M. Allos, M.S.A. El Rechim, and S. El Sharkaway Experience with the use of an investigational F(ab')2 heptavalent botulism immune globulin of equine origin during an outbreak of Type E botulism in Egypt Clin Infect Dis 23 1996 337 340
9. T.R. Gelzleichter, M.A. Myers, R.G. Menton, N.A. Niemuth, M.C. Matthews, and M.J. Langford Protection against botulinum toxins provided by passive immunization with botulinum human immune globulin: evaluation using an inhalation model J Appl Toxicol 19 Suppl. 1 1999 S35 S38
10. A. Casadevall Passsive antibody therapies: progress and continuing challenges Clin Immunol 93 1999 5 15
11. S. Bregenholt, and J. Haurum Pathogen-specific recombinant human polyclonal antibodies: biodefence applications Expert Opin Biol Ther 4 2004 387 396
12. S.M. Kipriyanov, and F. Le Gall Generation and production of engineered antibodies Mol Biotechnol 26 2004 39 60
13. K. Ko, and H. Koprowski Plant biopharming of monoclonal antibodies Virus Res 111 2005 93 100
14. V. Gomord, C. Sourrouille, A. Fitchette, M. Bardor, S. Pagny, and P. Lerouge Production and glycosylation of plant-made pharmaceuticals: the antibodies as a challenge Plant Biotechnol J 2 2004 83 100
15. P. Amersdorfer, C. Wong, S. Chen, T. Smith, S. Deshpande, and R. Sheridan Molecular characterization of murine humoral immune response to botulinum neurotoxin type A binding domain as assessed by using phage antibody libraries Infect Immun 65 1997 3743 3752
16. A. Nowakowski, C. Wang, D.B. Powers, P. Amersdorfer, T.J. Smith, and V.A. Montgomery Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody Proc Natl Acad Sci USA 99 2002 11346 11350
17. F. Olea-Popelka, M.D. McLean, J. Horsman, K.C. Almquist, J.E. Brandle, and J.C. Hall Increasing the expression of an anti-picloram single-chain variable fragment (scFv) antibody, and resistance to picloram, in transgenic tobacco (Nicotiana tabacum) J Agric Food Chem 53 2005 6683 6690
18. D.R. Hipfner, K.C. Almquist, B.D. Stride, R.G. Deeley, and S.P. Cole Location of a protease-hypersensitive region in the multidrug resistance protein (MRP) by mapping of the epitope of MRP-specific monoclonal antibody QCRL-1 Cancer Res 56 14 1996 3307 3314
19. A. Schouten, J. Roosien, F.A. van Engelen, G.A. de Jong, A.W. Borst-Vrenssen, and J.F. Zilverentant The C-terminal KDEL sequence increases the expression level of a single-chain antibody designed to be targeted to both the cytosol and the secretory pathway in transgenic tobacco Plant Mol Biol 30 4 1996 781 793
20. D.A. Samac, C.M. Hironaka, P.E. Yallaly, and D.M. Shah Isolation and characterization of the genes encoding basic and acidic chitinase in Arabidopsis thaliana Plant Physiol 93 1990 907 914
21. M. Timmermans, P. Maliga, J. Vieira, and J. Messing The pFF plasmids: cassettes utilising CaMV sequences for expression of foreign genes in plants J Biotechnol 14 1990 333 344
22. M. Bevan Binary Agrobacterium vectors for plant transformation Nucleic Acids Res 12 22 1984 8711 8721
23. B. Miki, S.G. McHugh, H. Labbe, T. Ouellet, J.H. Tolman, and J.E. Brandle Transgenic tobacco: gene expression and applications Biotechnol Agric For 45 1999 336 354
24. R.A. Schilperorrt S.B. Gelvin Plant molecular biology manual 2nd ed. 1995 Kluwer Academic Publishers London
25. K.C. Almquist, Y. Niu, M.D. McLean, F. Mena, K. Yau, and K. Brown Immunomodulation confers herbicide resistance in plants Plant Biotechnol J 2 2004 189 197
26. S. Sun, L.H. Nguyen, O. Harold Ross, G.F. Hollis, and R. Wynn Quantitative analysis of c-myc-tagged protein in crude cell extracts using fluorescence polarization Anal Biochem 307 2 2002 287 296
27. T.W. Smith, V.P. Butler Jr., E. Haber, H. Fozzard, F.I. Marcus, and W.F. Bremner Treatment of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments: experience in 26 cases N Engl J Med 307 22 1982 1357 1362
28. A.M. Ruha, S.C. Curry, M. Beuhler, K. Katz, D.E. Brooks, and K.A. Graeme Initial postmarketing experience with crotalidae polyvalent immune Fab for treatment of rattlesnake envenomation Ann Emerg Med 39 6 2002 609 615
29. P. Williamson, and R. Matthews Development of neutralising human recombinant antibodies to pertussis toxin FEMS Immunol Med Microbiol 23 4 1999 313 319
30. D.F. Cardoso, F. Nato, P. England, M.L. Ferreira, T.J. Vaughan, and I. Mota Neutralizing human anti crotoxin scFv isolated from a nonimmunized phage library Scand J Immunol 51 4 2000 337 344
31. L. Riano-Umbarila, V.R. Juarez-Gonzalez, T. Olamendi-Portugal, M. Ortiz-Leon, L.D. Possani, and B. Becerril A strategy for the generation of specific human antibodies by directed evolution and phage display. An example of a single-chain antibody fragment that neutralizes a major component of scorpion venom FEBS J 272 10 2005 2591 2601
32. C. Devaux, E. Moreau, M. Goyffon, H. Rochat, and P. Billiald Construction and functional evaluation of a single-chain antibody fragment that neutralizes toxin AahI from the venom of the scorpion Androctonus australis hector Eur J Biochem 268 3 2001 694 702
33. S. Schillberg, R.M. Twyman, and R. Fischer Opportunities for recombinant antigen and antibody expression in transgenic plants-technology assessment Vaccine 23 15 2005 1764 1769
34. L.S. Lee, C. Conover, C. Shi, M. Whitlow, and D. Filpula Prolonged circulating lives of single-chain Fv proteins conjugated with polyethylene glycol: a comparison of conjugation chemistries and compounds Bioconjug Chem 10 6 1999 973 981
35. M.S. Dennis, M. Zhang, Y.G. Meng, M. Kadkhodayan, D. Kirchhofer, and D. Combs Albumin binding as a general strategy for improving the pharmacokinetics of proteins J Biol Chem 277 38 2002 35035 35043
36. P. Holliger, M. Wing, J.D. Pound, H. Bohlen, and G. Winter Retargeting serum immunoglobulin with bispecific diabodies Nat Biotechnol 15 7 1997 632 636
37. P.J. Hudson, and A.A. Kortt High avidity scFv multimers; diabodies and triabodies J Immunol Methods 231 1-2 1999 177 189
38. C. Enever, I.M. Tomlinson, J. Lund, M. Levens, and P. Holliger Engineering high affinity superantigens by phage display J Mol Biol 347 1 2005 107 120
39. A.R. Lussow, R. Buelow, L. Fanget, S. Peretto, L. Gao, and P. Pouletty Redirecting circulating antibodies via ligand-hapten conjugates eliminates target cells in vivo J Immunother Emphasis Tumor Immunol 19 4 1996 257 265
40. J.D. Marks Deciphering antibody properties that lead to potent botulinum neurotoxin neutralization Mov Disord 19 Suppl. 8 2004 S101 S108
41. F.A. Montero-Julian, B. Klein, E. Gautherot, and H. Brailly Pharmacokinetic study of anti-interleukin-6 (IL-6) therapy with monoclonal antibodies: enhancement of IL-6 clearance by cocktails of anti-IL-6 antibodies Blood 85 4 1995 917 924
42. F. Brossier, M. Levy, A. Landier, P. Lafaye, and M. Mock Functional analysis of Bacillus anthracis protective antigen by using neutralizing monoclonal antibodies Infect Immun 72 11 2004 6313 6317
43. A. Dove Uncorking the biomanufacturing bottleneck Nat Biotechnol 20 8 2002 777 779
44. L. Joshi, and L.C. Lopez Bioprospecting in plants for engineered proteins Curr Opin Plant Biol 8 2 2005 223 226
45. J.L. Fox Puzzling industry response to ProdiGene fiasco Nat Biotechnol 21 1 2003 3 4
46. L. Bucchini, and L.R. Goldman Starlink corn: a risk analysis Environ Health Perspect 110 1 2002 5 13
47. Z. Lai, R. Kimmel, S. Petersen, S. Thomas, G. Pier, and B. Bezabeh Multi-valent human monoclonal antibody preparation against Pseudomonas aeruginosa derived from transgenic mice containing human immunoglobulin loci is protective against fatal pseudomonas sepsis caused by multiple serotypes Vaccine 23 25 2005 3264 3271
48. S. Bregenholt, and J. Haurum Pathogen-specific recombinant human polyclonal antibodies: biodefence applications Expert Opin Biol Ther 4 3 2004 387 396
49. C.L. Cramer, J.G. Boothe, and K.K. Oishi Transgenic plants for therapeutic proteins: linking upstream and downstream strategies Curr Top Microbiol Immunol 240 1999 95 118
50. A.C. Roque, C.R. Lowe, and M.A. Taipa Antibodies and genetically engineered related molecules: production and purification Biotechnol Prog 20 3 2004 639 654